Effects of niacin and Niaspan on HDL lipoprotein cellular SR-BI-mediated cholesterol efflux

Journal of Clinical Lipidology

Volumn 1, Issue 6, 2007, Pages 614-619

  Morgan, John M ^a   de la Llera Moya, Margarita ^b   Capuzzi, David M ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Cholesterol; Dyslipidemia; Efflux; HDL C; Niacin; SR BI

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PLACEBO; SCAVENGER RECEPTOR BI;

ADULT; AGED; ARTICLE; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORRELATION FUNCTION; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE TITRATION; DRUG MECHANISM; EXTENDED RELEASE FORMULATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMEDIATE RELEASE FORMULATION; IN VITRO STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

EID: 36849037410     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2007.09.003     Document Type: Article

References (19)

1. Maron D.J. The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am J Cardiol 86 suppl (2000) 11L-14L
2. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (1977) 707-714
3. Castelli W.P. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 4 suppl A (1988) 5A-10A
4. Gordon D.J., Probstfield J.L., Garrison R.J., et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 79 (1989) 8-15
5. Wang W.Q., Moses A.S., and Francis G.A. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers. Biochemistry 4012 (2001) 3666-3673
6. Asztalos B.F., Llera-Moya M., Dallal G.E., Horvath K.V., Schaefer E.J., and Rothblat G.H. Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. J Lipid Res 46 (2005) 2246-2253
7. Yancey P.G., Asztalos B.F., Stettler N., et al. SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome. J Lipid Res 45 (2004) 1724-1732
8. Morgan J.M., Capuzzi D.M., Baksh R.I., et al. Effects of extended-release niacin on lipoprotein subclass distribution. Am J Cardiol 91 (2003) 1432-1436
9. De la Llera M., Atger V., Paul J.L., et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Arterioscler Thromb 14 (1994) 1056-1065
10. Warnick G.R., Benderson J., and Albers J.J. Dextran sulfate-Mg21 precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin Chem 28 (1982) 1279-1288
11. Bachorik P.S., and Albers J.J. Precipitation methods for quantitation of lipids. Methods Enzymol 29 (1986) 78-100
12. Marcovina S.M., Albers J.J., Kennedy H., Mei J.V., Henderson L.O., and Hannon W.H. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. Clin Chem 40 (1994) 586-592
13. Brown G., Albers J.J., Fisher L.D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323 (1990) 1289-1298
14. de la Llera Moya M., Atger V., Paul J.L., et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 14 (1994) 1056-1065
15. Brites F.D., Bonavita C.D., De Geitere C., et al. Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels. Atherosclerosis 152 (2000) 181-192
16. Rubic T., Trottman M., and Lorenz R.L. Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette AI in monocytoid cells by niacin. Biochem Pharmacol 67 (2004) 411-419
17. Ganji S.H., Kamanna V.S., and Kashyap M.L. Niacin and cholesterol: role in cardiovascular disease [review]. J Nutr Biochem 14 (2003) 298-305
18. Chapman M.J., Assmann G., Fruchart J.C., Shepherd J., and Sirtori C. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid-a position paper developed by the European Consensus Panel on HDL-C. Curr Res Med Opin 20 (2004) 1253-1268
19. Kontush A., and Chapman M.J. Functionally defective high density lipoprotein; a new therapeutic target at the crossroads of dyslipidemia, inflammation and atherosclerosis. Pharmacol. Rev 58 (2006) 342-374